Scholarlink

Background <p>Following repeated botulinum toxin (BTX) treatments, patients with hemifacial spasm (HFS) are&#xa0;recommended to undergo microvascular decompression (MVD) for a permanent cure. Intraoperative lateral spread&#xa0;response (LSR) monitoring is important to improve surgical outcomes. However, LSR monitoring during MVD surgery&#xa0;in HFS patients who have previously received BTX is challenging, since the muscles typically used to assess the LSR&#xa0;are paralyzed. Here, we describe our use of the upper part of the orbicularis oculi and mentalis muscles for&#xa0;intraoperative monitoring of the LSR during MVD in HFS patients following BTX treatment.</p> Methods <p>HFS patients who underwent MVD surgery were divided into two groups based on their history of BTX&#xa0;treatment: BTX+ and BTX- groups. In the BTX+ group, MVD was performed at least 3 months after the last BTX&#xa0;injection. We measured LSR morphology, including the number of spikes, their duration, and maximum amplitude in&#xa0;all patients. We also measured intraoperative LSR disappearance rate, and the cure rate of HFS at the final follow-up&#xa0;(over 1 year after surgery).</p> Results <p>Although the waveforms showed a trend toward shorter durations with mandibular branch stimulation in the&#xa0;BTX+ group, there was no difference in the number of spikes or maximum amplitude values. There was no increase&#xa0;in LSR dysmetria after BTX treatment (BTX+ group: 32.8% vs. BTX- group: 31.9%). There was also no difference in&#xa0;intraoperative LSR disappearance rate between the two groups (BTX+ group: 68.3% vs. BTX- group: 74.6%).</p> Conclusion <p>Intraoperative LSR monitoring using the upper part of the orbicularis oculi muscle and the mentalis&#xa0;muscle at an interval of at least 3 months after the last BTX treatment might be a feasible monitoring technique&#xa0;during MVD for HFS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Intraoperative use of lateral spread response measurement in the upper orbicularis oculi and mandibular muscles in patients with hemifacial spasm after botulinum toxin treatment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月10日

查看全文
  • Yuki Amano,
  • Bunsho Asayama,
  • Shusaku Noro,
  • Takenori Abe,
  • Masahiro Okuma,
  • Ryota Nomura,
  • Kaori Honjo,
  • Yoshinobu Seo,
  • Hirohiko Nakamura

摘要

Background

Following repeated botulinum toxin (BTX) treatments, patients with hemifacial spasm (HFS) are recommended to undergo microvascular decompression (MVD) for a permanent cure. Intraoperative lateral spread response (LSR) monitoring is important to improve surgical outcomes. However, LSR monitoring during MVD surgery in HFS patients who have previously received BTX is challenging, since the muscles typically used to assess the LSR are paralyzed. Here, we describe our use of the upper part of the orbicularis oculi and mentalis muscles for intraoperative monitoring of the LSR during MVD in HFS patients following BTX treatment.

Methods

HFS patients who underwent MVD surgery were divided into two groups based on their history of BTX treatment: BTX+ and BTX- groups. In the BTX+ group, MVD was performed at least 3 months after the last BTX injection. We measured LSR morphology, including the number of spikes, their duration, and maximum amplitude in all patients. We also measured intraoperative LSR disappearance rate, and the cure rate of HFS at the final follow-up (over 1 year after surgery).

Results

Although the waveforms showed a trend toward shorter durations with mandibular branch stimulation in the BTX+ group, there was no difference in the number of spikes or maximum amplitude values. There was no increase in LSR dysmetria after BTX treatment (BTX+ group: 32.8% vs. BTX- group: 31.9%). There was also no difference in intraoperative LSR disappearance rate between the two groups (BTX+ group: 68.3% vs. BTX- group: 74.6%).

Conclusion

Intraoperative LSR monitoring using the upper part of the orbicularis oculi muscle and the mentalis muscle at an interval of at least 3 months after the last BTX treatment might be a feasible monitoring technique during MVD for HFS.